Literature DB >> 8908208

Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.

T Watanabe1, H Satoh, M Togoh, S Taniguchi, Y Hashimoto, K Kurokawa.   

Abstract

Among major eicosanoids and their analogs, prostaglandin (PG) F2 alpha > PGD2 > PGE1 > or = PGE2 > iloprost, a stable agonist of PGI2, dose-dependently stimulated DNA synthesis in quiescent NIH-3T3 cells. PGF2 alpha, PGD2, and PGE2, in that order, formed inositol phosphates and elevated intracellular Ca2+ ([Ca2+]i) but did not form cAMP nor inhibit forskolin-induced cAMP formation. Iloprost, PGI2, and PGE1 induced cAMP formation dose dependently with an ED50 of around 10(-7) M, and PGE2 at more than 10(-6) M did it. [3H]PGF2 alpha and [3H]PGD2 bindings membranes from NIH-3T3 cells were displaced in the order of PGF2 alpha > PGD2 > or = PGE2, while [3H]PGE2 binding was displaced by PGE2 > PGD2 > or = PGF2 alpha. Expression of mRNA encoding EP1 and EP4 (EP2) subtypes could be detected by reverse transcription- polymerase chain reaction using primers specific for EP1 and EP4 (EP2) cDNAs, but not that of EP3 subtype mRNA. The dose dependence of cAMP formation on iloprost and PGI2 and that of [Ca2+]i elevation on PGF2 alpha, D2, and E2 were similar to that of [3H]thymidine incorporation on the corresponding agonists. Fluprostenol (1 microM), a PGF2 alpha receptor agonist > 17-phenyl-trinor-PGE2 (1 microM), an EP1 receptor agonist stimulated [3H]thymidine incorporation, but an EP3 receptor agonist, ONO-AP-324 nor an EP4 (EP2) receptor agonist, 11-deoxy-PGE1 (1 microM) did not. Iloprost, dibutyryl cAMP, forskolin, or cholera toxin, when applied alone, enhanced [3H]thymidine incorporation, while they inhibited [3H]thymidine incorporation induced by submaximal concentrations of PGF2 alpha or epidermal growth factor (EGF), when applied within 12 hr after agonist stimulation. These results suggest that the proliferation of NIH-3T3 cells is stimulated by PGs via the PGF2 alpha receptor, EP1 subtype of PGE receptor, and the PGI2/PGE1 receptor through [Ca2+]i- and cAMP-dependent pathways, and that cAMP pathway negatively cross-talks with [Ca2+]i-or receptor tyrosine kinase-mediated DNA synthesis in a cell cycle-dependent manner.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8908208     DOI: 10.1002/(SICI)1097-4652(199611)169:2<401::AID-JCP20>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands.

Authors:  Jie Tian; Isabel Lambertz; Thomas R Berton; Joyce E Rundhaug; Kaoru Kiguchi; Stephanie H Shirley; John Digiovanni; Claudio J Conti; Susan M Fischer; Robin Fuchs-Young
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

2.  Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor.

Authors:  Pamela Harding; Margot C LaPointe
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-02-20       Impact factor: 4.006

Review 3.  Prostaglandin E2 and the pathogenesis of pulmonary fibrosis.

Authors:  Paul D Bozyk; Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-18       Impact factor: 6.914

4.  Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.

Authors:  Xinrong Ma; Namita Kundu; Olga B Ioffe; Olga Goloubeva; Raymond Konger; Claudia Baquet; Phyllis Gimotty; Jocelyn Reader; Amy M Fulton
Journal:  Mol Cancer Res       Date:  2010-09-21       Impact factor: 5.852

5.  The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing.

Authors:  Traci A Wilgus; Valerie K Bergdall; Kathleen L Tober; Kara J Hill; Srabani Mitra; Nicholas A Flavahan; Tatiana M Oberyszyn
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function.

Authors:  Namita Kundu; Xinrong Ma; Dawn Holt; Olga Goloubeva; Suzanne Ostrand-Rosenberg; Amy M Fulton
Journal:  Breast Cancer Res Treat       Date:  2008-09-16       Impact factor: 4.872

7.  Prostaglandin E2 differentially regulates contraction and structural reorganization of anchored collagen gels by human adult and fetal dermal fibroblasts.

Authors:  Aron Parekh; Vlad C Sandulache; Tripti Singh; Selma Cetin; Michael S Sacks; Joseph E Dohar; Patricia A Hebda
Journal:  Wound Repair Regen       Date:  2009 Jan-Feb       Impact factor: 3.617

8.  Crosstalk between EP2 and PPARα Modulates Hypoxic Signaling and Myopia Development in Guinea Pigs.

Authors:  Nethrajeith Srinivasalu; Sen Zhang; Renchang Xu; Peter Sol Reinach; Yongchao Su; Yun Zhu; Jia Qu; Xiangtian Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

9.  Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma.

Authors:  Ewa Pomianowska; Dagny Sandnes; Krzysztof Grzyb; Aasa R Schjølberg; Monica Aasrum; Ingun H Tveteraas; Vegard Tjomsland; Thoralf Christoffersen; Ivar P Gladhaug
Journal:  BMC Cancer       Date:  2014-06-09       Impact factor: 4.430

Review 10.  Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways.

Authors:  Vidyani Suryadevara; Ramaswamy Ramchandran; David W Kamp; Viswanathan Natarajan
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.